| 71839-125-25 |
71839-125 |
HUMAN PRESCRIPTION DRUG |
glycopyrrolate |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220310 |
N/A |
ANDA |
ANDA211705 |
BE Pharmaceuticals Inc. |
GLYCOPYRROLATE |
1 mg/5mL |
25 VIAL, MULTI-DOSE in 1 CARTON (71839-125-25) / 5 mL in 1 VIAL, MULTI-DOSE (71839-125-01) |
| 70069-013-25 |
70069-013 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220129 |
N/A |
ANDA |
ANDA211705 |
Somerset Therapeutics, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL in 1 CARTON (70069-013-25) / 5 mL in 1 VIAL (70069-013-01) |
| 65145-105-10 |
65145-105 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20250125 |
N/A |
ANDA |
ANDA211705 |
Caplin Steriles Limited |
GLYCOPYRROLATE |
4 mg/20mL |
10 VIAL, MULTI-DOSE in 1 CARTON (65145-105-10) / 20 mL in 1 VIAL, MULTI-DOSE (65145-105-01) |
| 71839-123-25 |
71839-123 |
HUMAN PRESCRIPTION DRUG |
glycopyrrolate |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220310 |
N/A |
ANDA |
ANDA211705 |
BE Pharmaceuticals Inc. |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (71839-123-25) / 1 mL in 1 VIAL, SINGLE-DOSE (71839-123-01) |
| 70069-011-25 |
70069-011 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220129 |
N/A |
ANDA |
ANDA211705 |
Somerset Therapeutics, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL in 1 CARTON (70069-011-25) / 1 mL in 1 VIAL (70069-011-01) |
| 65145-103-25 |
65145-103 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20250125 |
N/A |
ANDA |
ANDA211705 |
Caplin Steriles Limited |
GLYCOPYRROLATE |
.4 mg/2mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (65145-103-25) / 2 mL in 1 VIAL, SINGLE-DOSE (65145-103-01) |
| 71839-124-25 |
71839-124 |
HUMAN PRESCRIPTION DRUG |
glycopyrrolate |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220310 |
N/A |
ANDA |
ANDA211705 |
BE Pharmaceuticals Inc. |
GLYCOPYRROLATE |
.4 mg/2mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (71839-124-25) / 2 mL in 1 VIAL, SINGLE-DOSE (71839-124-01) |
| 70069-012-25 |
70069-012 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220129 |
N/A |
ANDA |
ANDA211705 |
Somerset Therapeutics, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL in 1 CARTON (70069-012-25) / 2 mL in 1 VIAL (70069-012-01) |
| 65145-104-25 |
65145-104 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20250125 |
N/A |
ANDA |
ANDA211705 |
Caplin Steriles Limited |
GLYCOPYRROLATE |
1 mg/5mL |
25 VIAL, MULTI-DOSE in 1 CARTON (65145-104-25) / 5 mL in 1 VIAL, MULTI-DOSE (65145-104-01) |
| 70069-014-10 |
70069-014 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220129 |
N/A |
ANDA |
ANDA211705 |
Somerset Therapeutics, LLC |
GLYCOPYRROLATE |
.2 mg/mL |
10 VIAL in 1 CARTON (70069-014-10) / 20 mL in 1 VIAL (70069-014-01) |
| 71839-126-25 |
71839-126 |
HUMAN PRESCRIPTION DRUG |
glycopyrrolate |
glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20220310 |
N/A |
ANDA |
ANDA211705 |
BE Pharmaceuticals Inc. |
GLYCOPYRROLATE |
4 mg/20mL |
25 VIAL, MULTI-DOSE in 1 CARTON (71839-126-25) / 20 mL in 1 VIAL, MULTI-DOSE (71839-126-01) |
| 65145-102-25 |
65145-102 |
HUMAN PRESCRIPTION DRUG |
Glycopyrrolate |
Glycopyrrolate |
INJECTION |
INTRAMUSCULAR; INTRAVENOUS |
20250125 |
N/A |
ANDA |
ANDA211705 |
Caplin Steriles Limited |
GLYCOPYRROLATE |
.2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (65145-102-25) / 1 mL in 1 VIAL, SINGLE-DOSE (65145-102-01) |